Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Pamidronate Disodium 30 MG Injection

Known as: PAMIDRONATE DISODIUM 3 mg in 1 mL INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION, PAMIDRONATE DISODIUM 30MG/VIL INJ [VA Product], PAMIDRONATE DISODIUM 30MG/VIL INJ 
 
National Institutes of Health

Related topics

Related topics

15 relations
10 ML Pamidronate Disodium 3 MG/ML InjectionDiphosphonatesDrug AllergyHypercalcemia
Expand

Broader (1)

HORMONES/SYNTHETICS/MODIFIERS,OTHER

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Bone targeted treatments in cancer – The story so far
  • R. Coleman
  • Journal of bone oncology
  • 2016
    • Corpus ID: 5522911
Bone targeted treatments have transformed the quality of life and physical functioning of patients with metastatic bone disease… Expand
2008
2008
Vδ2 T‐lymphocyte responses in cord blood samples from Italy and Côte d’Ivoire
Cord blood T lymphocytes are immature and their functional defect partially reflects a suboptimal level of costimulatory signals… Expand
2005
2005
PCN5 BUDGET IMPACT ANALYSIS OF INTRAVENOUS (IV) ZOLEDRONIC ACID VS. ORAL IBANDRONATE OR IV GENERIC PAMIDRONATE IN THE PREVENTION OF BONE COMPLICATIONS IN BREAST CANCER PATIENTS WITH BONE METASTASES…
PCN5 BUDGET IMPACT ANALYSIS OF INTRAVENOUS (IV) ZOLEDRONIC ACID VS. ORAL IBANDRONATE OR IV GENERIC PAMIDRONATE IN THE PREVENTION… Expand
1997
1997
P930. Supportive care with disodic pamidronate in the treatment of breast cancer metastatic bone lesions
 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE